REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Chengdu Olymvax Biopharmaceuticals Inc. (成都欧林生物科技股份有限公司) (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Chengdu Olymvax Biopharmaceuticals Inc. Profile Updated: January 10, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Chengdu Olymvax Biopharmaceuticals Inc. is dedicated to the research, development, production and sales of human vaccine. The company was founded in 2009 and headquartered in Chengdu City, China.

Headquarters
No. 99, Tianxin Road, High-tech Zone, Chengdu, Sichuan Province
Chengdu; Sichuan; Postal Code: 611731

Contact Details: Purchase the Chengdu Olymvax Biopharmaceuticals Inc. (成都欧林生物科技股份有限公司) report to view the information.

Website: http://www.olymvax.com

Basic Information
Total Employees:
Purchase the Chengdu Olymvax Biopharmaceuticals Inc. (成都欧林生物科技股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Chengdu Olymvax Biopharmaceuticals Inc. (成都欧林生物科技股份有限公司) report to view the information.
Registered Capital:
Purchase the Chengdu Olymvax Biopharmaceuticals Inc. (成都欧林生物科技股份有限公司) report to view the information.
Financial Auditors:
Purchase the Chengdu Olymvax Biopharmaceuticals Inc. (成都欧林生物科技股份有限公司) report to view the information.
Incorporation Date:
December 11, 2009
Key Executives
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
17.82%
Purchase this report to view the information.
7.53%
Purchase this report to view the information.
6.38%
Purchase this report to view the information.
3.87%
Purchase this report to view the information.
3.25%
Subsidiaries
Chongqing Yuanlun Biological Technology Co., Ltd.
100%
Chengdu Sinomin Biotechnology Co., Ltd.
88.62%
Company Performance
Financial values in the chart are available after Chengdu Olymvax Biopharmaceuticals Inc. (成都欧林生物科技股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
31.11%▲
Total operating revenue
31%▲
Operating profit (EBIT)
10594.4%▲
Net Profit (Loss) for the Period
N/A
Total Assets
13.9%▲
Total Equity
5.15%▲
Operating Profit Margin (ROS)
10.84%▲
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt/Equity
-0.43%▼
Quick Ratio
-0.25%▼
Cash Ratio
-0.13%▼

Similar companies

Sinopharm Group Company Limited
 
Shanghai Pharmaceuticals Holding Co.,Ltd
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
 
JD Health International Inc.
Nanjing Pharmaceutical Company Limited
 
Hubei Biocause Pharmaceutical Co.,Ltd.
Tiansheng Pharmaceutical Group Co., Ltd
 
Hangzhou Biotest Biotech Co.,Ltd.
Hainanhaiyao Co., Ltd.
 
Pharmaresources (Shanghai) Co., Ltd.
Hubei Goto Biopharm Co.,Ltd.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo